260 related articles for article (PubMed ID: 26775556)
61. Novel lncRNA Erbb4-IR Promotes Diabetic Kidney Injury in
Sun SF; Tang PMK; Feng M; Xiao J; Huang XR; Li P; Ma RCW; Lan HY
Diabetes; 2018 Apr; 67(4):731-744. PubMed ID: 29222368
[TBL] [Abstract][Full Text] [Related]
62. MicroRNA-21 protects from mesangial cell proliferation induced by diabetic nephropathy in db/db mice.
Zhang Z; Peng H; Chen J; Chen X; Han F; Xu X; He X; Yan N
FEBS Lett; 2009 Jun; 583(12):2009-14. PubMed ID: 19450585
[TBL] [Abstract][Full Text] [Related]
63. Effects of long non-coding RNA LINC00667 on renal tubular epithelial cell proliferation, apoptosis and renal fibrosis via the miR-19b-3p/LINC00667/CTGF signaling pathway in chronic renal failure.
Chen W; Zhou ZQ; Ren YQ; Zhang L; Sun LN; Man YL; Wang ZK
Cell Signal; 2019 Feb; 54():102-114. PubMed ID: 30555030
[TBL] [Abstract][Full Text] [Related]
64. Effect of rosmarinic acid on experimental diabetic nephropathy.
Jiang WL; Xu Y; Zhang SP; Hou J; Zhu HB
Basic Clin Pharmacol Toxicol; 2012 Apr; 110(4):390-5. PubMed ID: 22053730
[TBL] [Abstract][Full Text] [Related]
65. The Long Noncoding RNA 150Rik Promotes Mesangial Cell Proliferation via miR-451/IGF1R/p38 MAPK Signaling in Diabetic Nephropathy.
Zhang Y; Sun Y; Peng R; Liu H; He W; Zhang L; Peng H; Zhang Z
Cell Physiol Biochem; 2018; 51(3):1410-1428. PubMed ID: 30485837
[TBL] [Abstract][Full Text] [Related]
66. Long noncoding RNA MALAT1 regulates renal tubular epithelial pyroptosis by modulated miR-23c targeting of ELAVL1 in diabetic nephropathy.
Li X; Zeng L; Cao C; Lu C; Lian W; Han J; Zhang X; Zhang J; Tang T; Li M
Exp Cell Res; 2017 Jan; 350(2):327-335. PubMed ID: 27964927
[TBL] [Abstract][Full Text] [Related]
67. MiR-325-3p inhibits renal inflammation and fibrosis by targeting CCL19 in diabetic nephropathy.
Sun J; Wang J; Lu W; Xie L; Lv J; Li H; Yang S
Clin Exp Pharmacol Physiol; 2020 Nov; 47(11):1850-1860. PubMed ID: 32603491
[TBL] [Abstract][Full Text] [Related]
68. MicroRNA-122-5p ameliorates tubular injury in diabetic nephropathy via FIH-1/HIF-1α pathway.
Cheng L; Qiu X; He L; Liu L
Ren Fail; 2022 Dec; 44(1):293-303. PubMed ID: 35166173
[TBL] [Abstract][Full Text] [Related]
69. Inhibition of miRNA‑135a‑5p ameliorates TGF‑β1‑induced human renal fibrosis by targeting SIRT1 in diabetic nephropathy.
Zhang J; Zhang L; Zha D; Wu X
Int J Mol Med; 2020 Sep; 46(3):1063-1073. PubMed ID: 32705273
[TBL] [Abstract][Full Text] [Related]
70. Hemizygous deletion of CTGF/CCN2 does not suffice to prevent fibrosis of the severely injured kidney.
Falke LL; Dendooven A; Leeuwis JW; Nguyen TQ; van Geest RJ; van der Giezen DM; Broekhuizen R; Lyons K; Stoop R; Kemperman H; Schlingemann R; Joles JA; Goldschmeding R
Matrix Biol; 2012; 31(7-8):421-31. PubMed ID: 23199377
[TBL] [Abstract][Full Text] [Related]
71. Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.
Krupa A; Jenkins R; Luo DD; Lewis A; Phillips A; Fraser D
J Am Soc Nephrol; 2010 Mar; 21(3):438-47. PubMed ID: 20056746
[TBL] [Abstract][Full Text] [Related]
72. PTEN Regulates Renal Extracellular Matrix Deposit via Increased CTGF in Diabetes Mellitus.
Zhu L; Zhao S; Liu S; Liu Q; Li F; Hao J
J Cell Biochem; 2016 May; 117(5):1187-98. PubMed ID: 26447680
[TBL] [Abstract][Full Text] [Related]
73. Quercetin ameliorates diabetic nephropathy by reducing the expressions of transforming growth factor-β1 and connective tissue growth factor in streptozotocin-induced diabetic rats.
Lai PB; Zhang L; Yang LY
Ren Fail; 2012; 34(1):83-7. PubMed ID: 22011322
[TBL] [Abstract][Full Text] [Related]
74. MicroRNA-29b inhibits diabetic nephropathy in db/db mice.
Chen HY; Zhong X; Huang XR; Meng XM; You Y; Chung AC; Lan HY
Mol Ther; 2014 Apr; 22(4):842-53. PubMed ID: 24445937
[TBL] [Abstract][Full Text] [Related]
75. Differential microRNA Profiles Predict Diabetic Nephropathy Progression in Taiwan.
Chien HY; Chen CY; Chiu YH; Lin YC; Li WC
Int J Med Sci; 2016; 13(6):457-65. PubMed ID: 27279796
[TBL] [Abstract][Full Text] [Related]
76. Synergistic effects of sulfur dioxide and polycyclic aromatic hydrocarbons on pulmonary pro-fibrosis via mir-30c-1-3p/ transforming growth factor β type II receptor axis.
Wu M; Liang G; Duan H; Yang X; Qin G; Sang N
Chemosphere; 2019 Mar; 219():268-276. PubMed ID: 30543962
[TBL] [Abstract][Full Text] [Related]
77. Connective tissue growth factor modulates oral squamous cell carcinoma invasion by activating a miR-504/FOXP1 signalling.
Yang MH; Lin BR; Chang CH; Chen ST; Lin SK; Kuo MY; Jeng YM; Kuo ML; Chang CC
Oncogene; 2012 May; 31(19):2401-11. PubMed ID: 21927029
[TBL] [Abstract][Full Text] [Related]
78. Role of connective tissue growth factor in experimental radiation nephropathy in rats.
Liu DG; Wang TM
Chin Med J (Engl); 2008 Oct; 121(19):1925-31. PubMed ID: 19080126
[TBL] [Abstract][Full Text] [Related]
79. Effect of miR-21 on Renal Fibrosis Induced by Nano-SiO₂ in Diabetic Nephropathy Rats via PTEN/AKT Pathway.
Guo J
J Nanosci Nanotechnol; 2021 Feb; 21(2):1079-1084. PubMed ID: 33183446
[TBL] [Abstract][Full Text] [Related]
80. Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
Liu XQ; Jiang L; Lei L; Nie ZY; Zhu W; Wang S; Zeng HX; Zhang SQ; Zhang Q; Yard B; Wu YG
Clin Sci (Lond); 2020 Dec; 134(23):3175-3193. PubMed ID: 33241846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
